|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: CRISPR sickle cell, Parkinson's, pig-human chimera concerns
|
|
|
|
CRISPR gene editing has made rapid progress heading from bench to bedside. Perhaps the fastest has been its progress toward clinical use to combat sickle cell disease. We'll start with a new paper on one major effort here. CRISPR gene editing. This process often involves cutting DNA, which then can be used as an opening to make specific changes to the …
|
|
|
|
|
|
|
|
Goldwater Institute weighs in against FDA on Cell Surgical Network lawsuit appeal
|
|
|
|
An important appeals case is pending not just for the defendants Cell Surgical Network, et al., but also for the FDA. It could impact the stem cell field very broadly too. Cell Surgical Network lawsuit status Hopefully, we'll get a decision before the end of this year. Cell Surgical Network is a large chain of unproven stem cell clinics. Drs. …
|
|
|
|
|
|
|
|
Vivek Ramaswamy & his surprising stem cell start
|
|
|
|
Many of us first became aware of Vivek Ramaswamy as a Republican candidate for President. He was most well-known prior to that as a biotech leader. Given that biotech background, I decided to learn more about him. Surprisingly, his biomedical efforts may have started with stem cells. That caught my attention. This was way back during his time as an undergrad …
|
|
|
|
|
|
